FibroGen Minority Interest

FibroGen (FGEN) currently reports a minority interest of $21M as of June 2026. That compares with $42M in the prior-year period — down 48.8% year over year. Use the charts on this page to explore FibroGen's minority interest history and peer comparisons.

FibroGen's minority interest decreased from $42M to $21M — a 48.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

FibroGen reported $21M in minority interest as of June 2026. That compares with $42M in the prior-year period — down 48.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for FibroGen, and consider following FGEN for alerts when major investors trade the stock.

FibroGen is classified in the Healthcare sector. On minority interest, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FGEN with unrelated industries.